• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蚊媒病毒mRNA疫苗的研究进展

Research progress of mosquito-borne virus mRNA vaccines.

作者信息

Sun Ningze, Su Zhiwei, Zheng Xiaoyan

机构信息

Beijing Institute of Tropical Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory for Research on Prevention and Treatment of Tropical Diseases, Beijing, China.

出版信息

Mol Ther Methods Clin Dev. 2024 Dec 12;33(1):101398. doi: 10.1016/j.omtm.2024.101398. eCollection 2025 Mar 13.

DOI:10.1016/j.omtm.2024.101398
PMID:39834558
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11743085/
Abstract

In recent years, mRNA vaccines have emerged as a leading technology for preventing infectious diseases due to their rapid development and high immunogenicity. These vaccines encode viral antigens, which are translated into antigenic proteins within host cells, inducing both humoral and cellular immune responses. This review systematically examines the progress in mRNA vaccine research for major mosquito-borne viruses, including dengue virus, Zika virus, Japanese encephalitis virus, Chikungunya virus, yellow fever virus, Rift Valley fever virus, and Venezuelan equine encephalitis virus. Enhancements in mRNA vaccine design, such as improvements to the 5' cap structure, 5'UTR, open reading frame, 3'UTR, and polyadenylation tail, have significantly increased mRNA stability and translation efficiency. Additionally, the use of lipid nanoparticles and polymer nanoparticles has greatly improved the delivery efficiency of mRNA vaccines. Currently, mRNA vaccines against mosquito-borne viruses are under development and clinical trials, showing promising protective effects. Future research should continue to optimize vaccine design and delivery systems to achieve broad-spectrum and long-lasting protection against various mosquito-borne virus infections.

摘要

近年来,mRNA疫苗因其快速发展和高免疫原性,已成为预防传染病的一项领先技术。这些疫苗编码病毒抗原,病毒抗原在宿主细胞内被翻译为抗原蛋白,从而诱导体液免疫和细胞免疫反应。本综述系统地研究了针对主要蚊媒病毒的mRNA疫苗研究进展,这些病毒包括登革病毒、寨卡病毒、日本脑炎病毒、基孔肯雅病毒、黄热病病毒、裂谷热病毒和委内瑞拉马脑炎病毒。mRNA疫苗设计方面的改进,如对5'帽结构、5'非翻译区、开放阅读框、3'非翻译区和聚腺苷酸化尾的改进,显著提高了mRNA的稳定性和翻译效率。此外,脂质纳米颗粒和聚合物纳米颗粒的使用极大地提高了mRNA疫苗的递送效率。目前,针对蚊媒病毒的mRNA疫苗正在研发和临床试验中,显示出有前景的保护效果。未来的研究应继续优化疫苗设计和递送系统,以实现针对各种蚊媒病毒感染的广谱和持久保护。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a43b/11743085/6490cc013e7b/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a43b/11743085/6490cc013e7b/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a43b/11743085/6490cc013e7b/fx1.jpg

相似文献

1
Research progress of mosquito-borne virus mRNA vaccines.蚊媒病毒mRNA疫苗的研究进展
Mol Ther Methods Clin Dev. 2024 Dec 12;33(1):101398. doi: 10.1016/j.omtm.2024.101398. eCollection 2025 Mar 13.
2
Excellent capability for molecular detection of -borne dengue, Zika, and chikungunya viruses but with a need for increased capacity for yellow fever and Japanese encephalitis viruses: an external quality assessment in 36 European laboratories.在检测蚊媒传播的登革热、寨卡和基孔肯雅病毒方面具备出色的分子检测能力,但在黄热病和日本脑炎病毒检测能力方面有待提高:36家欧洲实验室的外部质量评估
J Clin Microbiol. 2025 Jan 31;63(1):e0091024. doi: 10.1128/jcm.00910-24. Epub 2024 Dec 16.
3
Arboviruses pathogenic for domestic and wild animals.对家养和野生动物具有致病性的虫媒病毒。
Adv Virus Res. 2014;89:201-75. doi: 10.1016/B978-0-12-800172-1.00005-7.
4
Development of nucleic acid-based vaccines against dengue and other mosquito-borne flaviviruses: the past, present, and future.登革热及其他蚊媒黄病毒核酸疫苗的研发:过去、现在与未来。
Front Immunol. 2025 Jan 7;15:1475886. doi: 10.3389/fimmu.2024.1475886. eCollection 2024.
5
Zika, Chikungunya, and Other Emerging Vector-Borne Viral Diseases. Zika、基孔肯雅热和其他新发的虫媒病毒病。
Annu Rev Med. 2018 Jan 29;69:395-408. doi: 10.1146/annurev-med-050715-105122. Epub 2017 Aug 28.
6
Trends in emerging vector-borne viral infections and their outcome in children over two decades.二十多年来新发的虫媒病毒感染及其儿童结局的趋势。
Pediatr Res. 2024 Jan;95(2):464-479. doi: 10.1038/s41390-023-02866-x. Epub 2023 Oct 25.
7
Mechanism of Immune Evasion in Mosquito-Borne Diseases.蚊媒疾病中的免疫逃逸机制
Pathogens. 2023 Apr 23;12(5):635. doi: 10.3390/pathogens12050635.
8
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial.在美国,使用乙型脑炎病毒或黄热病病毒疫苗进行初免成年人中,一种纯化的灭活寨卡病毒候选疫苗的安全性和免疫原性:一项 1 期、随机、双盲、安慰剂对照临床试验。
Lancet Infect Dis. 2023 Oct;23(10):1175-1185. doi: 10.1016/S1473-3099(23)00192-5. Epub 2023 Jun 27.
9
Aptamers isolated against mosquito-borne pathogens.针对蚊媒病原体分离的适配体。
World J Microbiol Biotechnol. 2021 Jul 9;37(8):131. doi: 10.1007/s11274-021-03097-0.
10
Vaccine development for mosquito-borne viral diseases.蚊媒病毒病疫苗的研发。
Front Immunol. 2023 May 12;14:1161149. doi: 10.3389/fimmu.2023.1161149. eCollection 2023.

引用本文的文献

1
mRNA Vaccine Development in the Fight Against Zoonotic Viral Diseases.用于对抗人畜共患病毒性疾病的mRNA疫苗研发
Viruses. 2025 Jul 8;17(7):960. doi: 10.3390/v17070960.
2
Why the Jenner/Pasteur paradigm is insufficient for controlling vector-borne diseases and the role of microbiota-mediated interactions.为什么詹纳/巴斯德范式不足以控制媒介传播疾病以及微生物群介导的相互作用的作用。
Curr Res Parasitol Vector Borne Dis. 2025 Jul 8;8:100291. doi: 10.1016/j.crpvbd.2025.100291. eCollection 2025.
3
Synergizing Attribute-Guided Latent Space Exploration (AGLSE) with Classical Molecular Simulations to Design Potent Pep-Magnet Peptide Inhibitors to Abrogate SARS-CoV-2 Host Cell Entry.

本文引用的文献

1
Single-cell analysis reveals an antiviral network that controls Zika virus infection in human dendritic cells.单细胞分析揭示了一个抗病毒网络,该网络控制人类树突状细胞中的寨卡病毒感染。
J Virol. 2024 May 14;98(5):e0019424. doi: 10.1128/jvi.00194-24. Epub 2024 Apr 3.
2
Evaluation of bird-adapted self-amplifying mRNA vaccine formulations in chickens.鸡用适应禽类的自我扩增mRNA疫苗制剂的评估。
Vaccine. 2024 Apr 19;42(11):2895-2908. doi: 10.1016/j.vaccine.2024.03.032. Epub 2024 Mar 23.
3
Approaches of dengue control: vaccine strategies and future aspects.
将属性引导的潜在空间探索(AGLSE)与经典分子模拟相结合,以设计有效的 Pep-Magnet 肽抑制剂来阻断 SARS-CoV-2 进入宿主细胞。
Viruses. 2025 Jun 7;17(6):828. doi: 10.3390/v17060828.
登革热控制方法:疫苗策略和未来展望。
Front Immunol. 2024 Feb 29;15:1362780. doi: 10.3389/fimmu.2024.1362780. eCollection 2024.
4
Can the Revolution in mRNA-Based Vaccine Technologies Solve the Intractable Health Issues of Current Ruminant Production Systems?基于信使核糖核酸的疫苗技术革命能否解决当前反刍动物生产系统中棘手的健康问题?
Vaccines (Basel). 2024 Jan 31;12(2):152. doi: 10.3390/vaccines12020152.
5
mRNA Delivery: Challenges and Advances through Polymeric Soft Nanoparticles.mRNA 递送:通过聚合物软纳米颗粒的挑战与进展。
Int J Mol Sci. 2024 Feb 1;25(3):1739. doi: 10.3390/ijms25031739.
6
Pharmacokinetic Analyses of a Lipid Nanoparticle-Encapsulated mRNA-Encoded Antibody against Rift Valley Fever Virus.脂质纳米颗粒包裹的编码抗裂谷热病毒抗体的药代动力学分析。
Mol Pharm. 2024 Mar 4;21(3):1342-1352. doi: 10.1021/acs.molpharmaceut.3c01016. Epub 2024 Jan 31.
7
Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults.儿童和成人中使用减毒活、四价 Butantan-登革热疫苗。
N Engl J Med. 2024 Feb 1;390(5):397-408. doi: 10.1056/NEJMoa2301790.
8
mRNA Vaccine Nanoplatforms and Innate Immunity.mRNA 疫苗纳米平台与固有免疫。
Viruses. 2024 Jan 14;16(1):120. doi: 10.3390/v16010120.
9
Nanoparticle technology for mRNA: Delivery strategy, clinical application and developmental landscape.mRNA 纳米颗粒技术:递呈策略、临床应用和发展前景。
Theranostics. 2024 Jan 1;14(2):738-760. doi: 10.7150/thno.84291. eCollection 2024.
10
A Rift Valley fever mRNA vaccine elicits strong immune responses in mice and rhesus macaques.一种裂谷热信使核糖核酸疫苗在小鼠和恒河猴中引发强烈的免疫反应。
NPJ Vaccines. 2023 Oct 27;8(1):164. doi: 10.1038/s41541-023-00763-2.